Notícias

Most retirees assume hitting a $68,400 annual income floor demands either a massive nest egg or risky high-yield instruments, but five ordinary dividend stocks across five sectors challenge both assumptions in ways the math makes hard to ignore.

Philip Morris has transformed from a declining tobacco play into a higher-margin, smoke-free growth story. Here's why I'm changing my mind on PM.

MO's on! PLUS is gaining retail share and nationwide reach, with new strengths and flavors set to broaden its nicotine pouch lineup in 2026.

Philip Morris has surpassed the broader consumer staples sector over the past year, and analysts remain moderately optimistic about the stock’s prospects.

The transition Altria once said it would lead now rests on a single nicotine pouch brand, while the number it newly emphasizes is about defending cigarettes.

The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta year in and year out often become the legends of the investing world.

MO and PM advance their smoke-free strategies as each leverages portfolio strength, innovation and pricing in a shifting tobacco market.

Why Altria Group’s New Manufacturing Deal Matters Now Altria Group (MO) has entered into reciprocal contract manufacturing arrangements with Philip Morris International, aiming to improve production efficiency and operational flexibility, with first shipments planned for 2027 and no expected material impact on 2026 results. Altria Group’s share price has climbed 20.61% year to date to US$69.12, with a 1-day share price return of 1.54% and a 7-day share price return of 4.68%, even though the...

Verizon, Altria and United Parcel Service are among the companies with dividend yields that match or beat bonds and also boast solid earnings prospects.

MO's PM manufacturing deal targets greater tobacco efficiency, supporting investment as cigarette volumes remain under pressure.

Download the Complete Report Here AIR Global PLC (AIIR) Best-in-Class Execution Despite Supply Chain Disruption; 2H Recovery and NGC Progress Support Outlook. Valuation Remains Attractive. Key Takeaways: Best-in-class execution supported 3.7% revenue growth and stable adj. EBITDA despite an FSM shipment decline during the Hormuz disruption. Americas led regional earnings growth, with adj. EBITDA up […] The post AIR Global’s Best-in-Class 1H Performance Amid Disruptions, 2H Recovery – Quarterly U

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.

Altria Group, Inc. (NYSE:MO) and Philip Morris International Inc. (NYSE:PM) have entered into reciprocal contract manufacturing arrangements designed to improve manufacturing efficiency and expand their operational flexibility. The first shipments are expected in 2027, while both companies said the agreements are not expected to have a material impact on their 2026 results. The deal is […]

Philip Morris stock rallies on a strategic agreement with Altria. Here's what makes PM shares worth owning in the back half of 2026.

One staples giant is separating from slower-moving rivals

PM's FDA authorization for 11 ZYN ULTRA nicotine pouches expands its U.S. smoke-free portfolio and supports the long-term transformation.

Earlier this week, Philip Morris International reported past Q2 2026 results with year-on-year growth in both revenue and net income, while its affiliate Swedish Match USA received FDA Marketing Granted Orders for 11 ZYN ULTRA moist oral nicotine pouch products, including all 9mg variants and one 11mg variant. This combination of stronger earnings and expanded FDA-authorized smoke-free products highlights how Philip Morris International is deepening its shift away from combustible...

Philip Morris International stock has delivered a strong 132.9% return over the past five years, while the latest Discounted Cash Flow (DCF) intrinsic value estimate points to the shares trading at a 17.3% discount to that valuation. However, the broader checks still flag the stock as only a limited-value opportunity. Recent attention around nicotine pouches, including new U.S. regulatory approvals, adds a fresh layer for investors weighing what that mix really means for pricing today. Over...

Philip Morris International (PM) drew fresh attention after the U.S. Food and Drug Administration granted Marketing Granted Orders for 11 ZYN ULTRA moist oral nicotine pouch products sold by its affiliate Swedish Match USA. See our latest analysis for Philip Morris International. At a share price of US$188.23, Philip Morris International has seen short term share price weakness, with the 30 day share price return declining 3.12%, while its year to date share price return of 17.42% and five...

The fair value estimate for Philip Morris International has been updated from US$193.14 to US$203.80, indicating a slightly higher implied price target range. That change is consistent with recent analyst commentary that considers ongoing IQOS and ZYN execution, the resilience of combustibles, and mixed views on 2026 risks and currency pressure. Read on to see how this evolving narrative could influence your view of Philip Morris International and how to track future developments in the...

Altria's pricing, margin gains and cash returns support earnings, but falling cigarette volumes and a premium to its median valuation keep the case balanced.

MO's Q2 earnings grow despite a miss, while a higher 2026 guidance floor puts more weight on pricing, margins and second-half execution.

Philip Morris (PM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

By Karen Roman AIR Global PLC (Nasdaq: AIIR) said first half revenue increased 3.7% to $206.9 million due to flavored shisha molasses revenue growth of 3.4% to $204.7 million, while gross profit rose 2.4% to $116.8 million. Adjusted EBITDA was $71.7 million, flat year-over-year, related to lower shipment volumes partially offset by U.S. tariff refunds. […] The post AIR Global Reports 1H Revenue & Gross Profit Growth, Maintains 2026 Guidance appeared first on ExecEdge.

Philip Morris International Inc. (NYSE:PM) and Altria Group, Inc. (NYSE:MO) often come up in the same conversation when investors look for tobacco dividend stocks. Both have long histories of returning cash to shareholders, but their dividend stories are starting to look quite different. Altria offers much more income upfront, while Philip Morris is growing its […]

<body><p>STORY: Could nicotine pouches become big tobacco's next big growth business?</p><p>:: Hugo Lhomedet, News reporter</p><p>:: Gdansk, Poland / August 18, 2026</p><p>:: Fast growth and higher margins</p><p>"Pouches do not produce smoke or vapor, so people can use them in many places where smoking or vaping is restricted. They're also growing faster than vapes or heated tobacco products, and companies say they generate strong margins.</p><p>"For tobacco groups like Philip Morris and BAT, pouches are also a category where they have strong brands, such as Zyn and Velo. That is different from vaping, where Chinese companies control much of the market."</p><p>:: Can success travel?</p><p>"Pouches are already well established in Scandinavia and in the United States. Tobacco companies are now seeing growth in markets including Britain and Poland, but it's not clear that success will travel everywhere. The main obstacle is cultural. In many countries people are used to getting nicotine by inhaling it, through cigarettes or vapes, rather than using a neural product. So to grow beyond those core markets, companies will have to convince consumers to try a very different way of using nicotine."</p><p>:: Lower health risks?</p><p>"For smokers who switch completely, pouches may reduce health risks compared with cigarettes. The FDA says that moving fully away from smoking to alternatives, including pouches, can lower risk. An experience in Sweden and Norway suggests oral nicotine products are substantially less harmful than smoking, but they are not risk-free. Health groups and regulators are increasingly worried about youth use, high nicotine strength and marketing practices. So the industry's opportunity also comes with a risk."</p><p>:: Lighter regulation for now</p><p>"Pouches have faced lighter regulation than some alternatives in many countries, but that is beginning to change, and tighter rules could slow their growth."</p></body>

By Hugo Lhomedet and Emma Rumney Aug 18 (Reuters) - Fast-growing nicotine pouches have emerged as one of Big Tobacco's most important bets on a future beyond cigarettes, offering rapid growth,

Philip Morris currently trades at $190.49 per share and has shown little upside over the past six months, posting a middling return of 3.7%. The stock also fell short of the S&P 500’s 13.9% gain during that period.

MO gains 12.8% YTD as smoke-free growth and pricing support earnings, but cigarette declines and oral tobacco weakness temper the outlook.

High-yield ETFs built purely on yield rankings carry a hidden flaw that only shows up when it's too late, and one fund uses a decade-long dividend track record as a filter before yield ever enters the picture.